Comparing Synthetic Hybrid-Scale Fiber Matrix With Standard of Care in Treating Diabetic Foot Ulcers
Assessment of Wound Closure Comparing Synthetic Hybrid-Scale Fiber Matrix With Standard of Care in Treating Diabetic Foot Ulcer
Sponsor: Acera Surgical, Inc.
Listed as NCT04918784, this NA trial focuses on Diabetic Foot Ulcer and remains completed. Sponsored by Acera Surgical, Inc., it has been updated 8 times since 2021, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Oct 2023 — Jul 2024 [monthly]
Completed NA
-
Jan 2023 — Oct 2023 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Dec 2022 — Jan 2023 [monthly]
Active Not Recruiting NA
▶ Show 3 earlier versions
-
Nov 2022 — Dec 2022 [monthly]
Active Not Recruiting NA
-
Sep 2022 — Nov 2022 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Sep 2021 — Sep 2022 [monthly]
Recruiting NA
First recorded
May 2021
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Acera Surgical, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .